Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

about

The expanding role of prophylaxis with recombinant activated factor VII.Bleeding management in pediatric patients.

P2860

Q43051388-D091934D-7D5F-4BEE-B4B7-9B331EA541BA Q45881678-FD2F2FE2-5418-490C-B4AF-7374ED99B74C

P2860

Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

Item

http://www.wikidata.org/entity/Q42139661

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@en

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@nl

type

Item

label

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@en

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@nl

prefLabel

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@en

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@nl

P1476

Innovative use of recombinant ...... th Glanzmann's thromboasthenia

@en

P2093

Anna Rita Cappiello

http://www.w3.org/2001/XMLSchema#string

Federica Valente

http://www.w3.org/2001/XMLSchema#string

Giuseppe Lassandro

http://www.w3.org/2001/XMLSchema#string

Riccardina Tesse

http://www.w3.org/2001/XMLSchema#string

Stefania Longo

http://www.w3.org/2001/XMLSchema#string

P2860

Glanzmann thrombasthenia

The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.

Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score.

Platelet function disorders.

Glanzmann's thrombasthenia: an overview.

Imaging of musculoskeletal complications of hemophilia.

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.

Sonography for assessment of haemophilic arthropathy in children: a systematic protocol.

The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis?

P304

143-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2450/2012.0016-12

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Giordano

Antonio Coppola

P577

2012-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229081317

http://www.w3.org/2001/XMLSchema#string

P698

22790269

http://www.w3.org/2001/XMLSchema#string

P921

An Eadailt

P932

3557485

http://www.w3.org/2001/XMLSchema#string

Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

about

P2860

P2860

Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932